Aortic transgraft hemorrhage after systemic thrombolytic therapy

Annals of Vascular Surgery

Volumn 11, Issue 3, 1997, Pages 292-294

  Pope, Marc ^a,b   Kalman, Peter G ^a,b,c  

^a University of Toronto ^*

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; DIGOXIN; ECASA 325; FIBRINOLYTIC AGENT; HEPARIN; METOLAZONE; NIFEDIPINE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; WARFARIN;

ACUTE HEART INFARCTION; AGED; AORTA ANEURYSM; AORTA GRAFT; ARTICLE; BLEEDING; CASE REPORT; DACRON IMPLANT; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030907292     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100169900048     Document Type: Article

References (7)

1. The GUSTO investigators. An international randomized trial comparing four thromholytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
2. London NJM, Williams B, Stein A. Systemic thrombolysis causing haemorrhage around a prosthetic abdominal aortic graft. Br Med J 1993;306:1530-1531.
3. Becker GJ, Holden RW, Rabe FE. Contrast extravasation from a Gore-Tex graft: a complication of thrombolytic therapy. Am J Radiol 1984;142:573-574.
4. Berger K, Sauvage LR, Rao AM, Wood SJ. Healing of arterial prostheses in man: its incompleteness. Ann Surg 1972;175: 118-127.
5. Ward AS, Cripps N. Remote transgraft hemorrhage complicating thrombolysis with tissue plasminogen activator. Am J Radiol 1993;161:1335-1336.
6. Perler BA, Kinnison M, Halden WJ. Transgraft hemorrhage: a serious complication of low-dose thrombolytic therapy. J Vasc Surg 1986;3:936-938.
7. Rabe FE, Becker GJ, Richmond BD, et al. Contrast extravasation through Dacron grafts: a sequela of low-dose streptokinase therapy. Am J Radiol 1982;138:917-920.